Colon and Rectal Cancers: Pathologic Staging and Assessment

A Continuing Medical Education Activity sponsored by InforMEDical Communications, Inc.

InforMEDical Communications, Inc. • 83 Acton Street • Carlisle, MA 01741
tel: 978-318-9582 • fax: 978-318-9583 • email: info@informedicalcme.com

This CME has expired.
For a list of active online CME, please click here.

CME Information

Up to 2 AMA PRA Category 1 Credit(s)™

Release date: August 2009        Valid through: August 2010

Course Material: Online Only

Receiving CME Credit

To receive online CME credit for this activity, read the full activity then click below to complete the post-test and evaluation. You will be able to print your CME certificate immediately following completion of the post-test and evaluation.

Target Audience
This activity is intended for surgeons, oncologists, pathologists, and other medical professionals who assess, counsel or treat patients with colon and rectal cancers.

Educational Objectives
Following completion of this activity, participants should be able to:

  • Discuss key updates in colorectal cancer staging and assessment based on the 2009 7th Edition of the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC).
  • Describe pathologic challenges affecting accuracy of assessment in stage II (lymph node negative) colorectal cancer.
  • Describe principal issues that physicians should be aware of in reviewing a pathology report for colorectal cancer.
  • Assess whether your institution’s practice of lymph node assessment for staging colon and rectal cancers is consistent with current recommended practice and if not, what you believe needs to be done to improve practice.
  • Assess whether your institution’s practice of developing and/or using pathology reports is consistent with new AJCC recommendations and if not, what you believe needs to be done to improve practice.
  • Integrate new criteria into practice.

Overview
Accurate staging information is essential for optimal patient management and the delivery of quality cancer care. This activity presents the key elements of stage determination and reporting for colorectal cancer, based on updated 2009 guidelines, and discusses the key prognostic features of pathological assessment of a colorectal resection specimen. 

Program Faculty
Carolyn C. Compton, MD, PhD
Adjunct Professor of Pathology
The Johns Hopkins University School of Medicine
Baltimore, Maryland

Sponsorship and Accreditation
This CME activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) by InforMEDical Communications, Inc. InforMEDical is accredited by the ACCME to provide continuing medical education for physicians and takes responsibility for the content, quality and scientific integrity of this CME activity.

Credit Designation
InforMEDical designates this continuing medical education activity for up to 2 AMA PRA Category 1 Credits™. Participants should only claim credit commensurate with the extent of their participation in the activity.

Educational Grant Support
The program is supported by an educational grant provided by sanofi-aventis, US.

Financial Disclosure
Faculty: Carolyn C. Compton, MD, PhD: nothing to disclose. Peer Reviewers: Anton Bilchik, MD, PhD, FACS: nothing to disclose; Heidi Nelson, MD: nothing to disclose.  InforMEDical: staff responsible for planning and editing content have no financial relationships to disclose.

This educational activity may contain discussion of published and/or investigational uses of agents, devices or diagnostics tools that have not been approved for use by the US FDA. The opinions expressed in the activity are those of the authors, and do not reflect those of the industry supporters or CME sponsor. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, contradictions and warnings. Participants/readers should appraise the information presented critically and are encouraged to consult appropriate resources for any product, device or diagnostic tool mentioned in this activity.

 

NEXT > >